Key facts
- Xact Labs has been issued U.S. Patent No. 12,640,242.
- The patent relates to genetic data integration for precision medicine.
- The technology is designed for integration across healthcare technology, pharmacy, and payer markets.
The issuance of this patent signifies a development in Xact Labs' efforts to build infrastructure for precision medicine. The technology aims to streamline the integration of genetic data, which is crucial for personalized treatment approaches in healthcare.